한국임상약학회지 (Korean Journal of Clinical Pharmacy)
- 제14권1호
- /
- Pages.1-10
- /
- 2004
- /
- 1226-6051(pISSN)
- /
- 2508-786X(eISSN)
5-Fluorouracil, Leucovorin과 병용 투여된 Oxaliplatin의 Dose Intensity가 재발된 전이성 대장암 치료에 미치는 영향
Dose Intensity of Oxaliplatin in 5-Fluorouracil and Leucovorin Regimens in Pretreated Metastatic Colorectal Cancer
- Jeong, Kyong-Ju (Graduate School of Clinical Pharmacy, Sookmyung Women's University) ;
- Choi, Seung-Ki (Department of Pharmacy, Pundang CHA General Hospital) ;
-
Oh, Jung-Mi
(Department or Pharmacology, College of Medicine, Pochon CHA University)
- 발행 : 2004.06.01
초록
Studies of oxaliplatin, 5-fluorouracil and leucovorin in pretreated metastatic colorectal cancer showed that oxaliplatin dose intensity is important prognostic factor for objective response rates and progression-free-survival (PFS). To evaluate response rates, PFS and toxicity according to oxaliplatin dose intensity, we retrospectively analyzed data from patients with metastatic colorectal cancer received oxaliplatin,5-fluorouracil, leucovorin regimens. Sixty-three patients were reviewed in this study, 42 patients received low dose intensity oxaliplatin (LDI:
키워드